156 related articles for article (PubMed ID: 6356007)
1. Nervous system-specific enolase in serum as a marker for neuroblastoma.
Ishiguro Y; Kato K; Ito T; Nagaya M; Yamada N; Sugito T
Pediatrics; 1983 Nov; 72(5):696-700. PubMed ID: 6356007
[TBL] [Abstract][Full Text] [Related]
2. Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Ishiguro Y; Kato K; Ito T; Horisawa M; Nagaya M
Gan; 1984 Jan; 75(1):53-60. PubMed ID: 6327451
[TBL] [Abstract][Full Text] [Related]
3. Determination of three enolase isozymes and S-100 protein in various tumors in children.
Ishiguro Y; Kato K; Ito T; Nagaya M
Cancer Res; 1983 Dec; 43(12 Pt 1):6080-4. PubMed ID: 6315226
[TBL] [Abstract][Full Text] [Related]
4. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.
Ishiguro Y; Kato K; Shimizu A; Ito T; Nagaya M
Clin Chim Acta; 1982 May; 121(2):173-80. PubMed ID: 7046994
[TBL] [Abstract][Full Text] [Related]
5. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
6. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
[TBL] [Abstract][Full Text] [Related]
7. Creatine kinase B subunit as a biomarker for small cell carcinoma of the lung: comparison with gamma-enolase.
Kato K; Ariyoshi Y; Nakajima T
Jpn J Cancer Res; 1985 Dec; 76(12):1162-7. PubMed ID: 3005208
[TBL] [Abstract][Full Text] [Related]
8. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
Cooper EH
Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499
[TBL] [Abstract][Full Text] [Related]
9. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
10. Practicable enzyme immunoassay for neuron-specific enolase in human serum.
Kimura S; Uchikawa H; Yamamoto R; Kato K
J Appl Biochem; 1984; 6(5-6):319-24. PubMed ID: 6399287
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma.
Zeltzer PM; Marangos PJ; Sather H; Evans A; Siegel S; Wong KY; Dalton A; Seeger R; Hammond D
Prog Clin Biol Res; 1985; 175():319-29. PubMed ID: 3991735
[No Abstract] [Full Text] [Related]
12. [Neuron specific enolase].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():717-9. PubMed ID: 16149621
[No Abstract] [Full Text] [Related]
13. [Gamma-enolase (gamma-eno)].
Koyama R
Nihon Rinsho; 1995 May; 53(5):1277-81. PubMed ID: 7602791
[TBL] [Abstract][Full Text] [Related]
14. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
16. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
18. Enolase isozymes in renal tubules and renal cell carcinoma.
Haimoto H; Takashi M; Koshikawa T; Asai J; Kato K
Am J Pathol; 1986 Sep; 124(3):488-95. PubMed ID: 3766707
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
